RARA CRAFT DATABASE for FDA Medical Devices

FDA Guidance and Notices, July 2026: MDUFA VI Proposals and FY2027 Device User Fees

日本語版

Two user fee items landed in July 2026. On July 8, FDA published in the Federal Register its proposed reauthorization package for the Medical Device User Fee Amendments covering fiscal years 2028 through 2032 (MDUFA VI), including a draft commitment letter with review-time goals. A public meeting was set for August 5, and comments were due August 7. On July 30 came the fee rates for fiscal year 2027, with a standard 510(k) fee of $28,653.

On the guidance side, FDA revised its final recommendations for 510(k) submissions for hemodialysis blood tubing sets. And since July 1, the Total Product Life Cycle Advisory Program (TAP) has accepted enrollment requests in all Offices of Health Technology (OHTs), the review offices of FDA's Center for Devices and Radiological Health (CDRH).

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles